As the astrocytic marker S100B also showed increases in early (Peskind et al., 2001) and more advanced AD (Petzold et al., 2003), whilst findings related to glutamine synthetase have been conflicting (Tumani et al., 1999; Timmer et al., 2015). Here, S100B is linked to Alzheimer disease.